| Table 1. Clinical characteristics of the subjects included in the study | ||||
| Period stored | Samples (n) | Frequency (%) | Clinic diagnosis | Years-old |
| 1. Study Group | ||||
| 12 years | 1 | 4.35 | Testis tumor | 30 |
| 10 years | 1 | 4.35 | Pre-Chemotherapy (non-informed tumor) | 39 |
| 1 | 4.35 | Testis tumor | 37 | |
| 1 | 4.35 | Pre-Chemotherapy (non-informed tumor) | 17 | |
| 1 | 4.35 | Pre-Chemotherapy (non-informed tumor) | 39 | |
| 9 years | 1 | 4.35 | Penis tumor | 32 |
| 1 | 4.35 | Leukemia | 21 | |
| 1 | 4.35 | Osteosarcoma | 16 | |
| 1 | 4.35 | Testis nodule | 36 | |
| 8 years | 1 | 4.35 | Sigmoid adenocarcinoma | 40 |
| 6 years | 1 | 4.35 | Pre-Chemotherapy (non-informed tumor) | 39 |
| 5 years | 1 | 4.35 | Pre-Chemotherapy (non-informed tumor) | 39 |
| 3 years | 4 | 17.38 | Mediastinal Seminoma | 22 |
| 6 | 26.08 | Pre-Chemotherapy (non-informed tumor) | 14 | |
| 1 | 4.35 | Testis tumor | 28 | |
| Total | 23 | 100 | Mean = 29.93±9.57y.o. | |
| 2. Validation Group | ||||
| 24 hours | 1 | 10 | Leukemia | 28 |
| 2 | 20 | Testis tumor | 23 | |
| 22 | ||||
| 1 | 10 | Sarcoma | 16 | |
| 1 | 10 | Lymphoma | 19 | |
| 1 | 10 | Nasopharynges cancer | 15 | |
| 1 | 10 | Rhabdomyosarcoma | 20 | |
| 1 | 10 | Adenocarcinoma | 37 | |
| 1 | 10 | Hypophysis macroadenoma | 20 | |
| 1 | 10 | Mediastinal tumor | 18 | |
| Total | 10 | 100 | Mean = 21.80±6.49y.o. | |